Patent on abuse-resistant drug to expire

Jan. 13, 2013 at 11:09 AM

LOUISVILLE, Ky., Jan. 13 (UPI) -- The patent on an abuse-resistant type of OxyContin will expire in April, leading to worries that generics will flood the Kentucky market again, activists said.

The (Louisville, Ky.) Courier-Journal said the new version of the pill turns into a gummy substance if an addict tries to crush it for injection.

But activists said when it disappears from the market in April, generic drugs with no abuse-resistant technology will likely take its place.

"You'll see a lot more oxycodone abuse again. You'll see a lot of overdoses. You'll see the ER visits. You'll see the funeral homes pick up business," Joshua Huffman, a 31-year-old recovering pill addict and anti-drug activist from Pikeville, Ky, said.

U.S. Rep. Hal Rogers, R-5th District, said he is working on a bill that will force the U.S. Food and Drug Administration to deny applicants for generic drugs that don't use abuse-resistant technologies, the newspaper reported.

But some in the drug business said legitimate patients take most of the pills, and generics cost them much less than the abuse-resistant technologies.

Related UPI Stories
Latest Headlines
Trending Stories
Females with childhood ADHD at double the risk for obesity
Medicaid-paid births up in Texas since defunding Planned Parenthood
New ethics standards for DNA replacement therapies
New screening method detects all cystic fibrosis mutations
Esophageal cooling device helps doctors control body temperature